Luguo Sun

1.7k citations
65 papers · 1.3k · h-index 20

Impact in

    • Cancer-related molecular mechanisms research
    • MicroRNA in disease regulation
    • Muscle Physiology and Disorders
    • Histone Deacetylase Inhibitors Research
    • RNA Research and Splicing
    • RNA modifications and cancer
    • Ubiquitin and proteasome pathways

Papers in

    • RNA Research and Splicing 9
    • Histone Deacetylase Inhibitors Research 8
    • RNA modifications and cancer 6
    • Epigenetics and DNA Methylation 6
    • Protein Degradation and Inhibitors 5
    • Natural product bioactivities and synthesis 4
    • MicroRNA in disease regulation 4

Luguo Sun

63 papers receiving 1.3k citations

Peers

Luguo Sun
Comparison fields: 5 of 108
  • Cancer Research 190
  • Molecular Biology 745
  • Periodontics 43
  • Complementary and alternative medicine 69
  • Food Science 118
Replace Yongli Bao with:
Yongli Bao China
Lan Lu China
Chunlei Yu China
Wen Zhao China
Seemi Farhat Basir India
Young–Jin Son South Korea
Víctor Ermilo Arana‐Argáez Mexico
Weisen Zeng China
Bing‐Hung Chen Taiwan
Arielle Rowe South Africa
Luguo Sun relative to Yongli Bao China Yongli Bao's profile →
Citations per field
00.5×1.5×
Yongli Bao · 1×
Citations per year

Countries citing papers authored by Luguo Sun

Since Specialization
Citations

This map shows the geographic impact of Luguo Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luguo Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luguo Sun more than expected).

Fields of papers citing papers by Luguo Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luguo Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luguo Sun. The network helps show where Luguo Sun may publish in the future.

Co-authors

The 25 scholars most cited alongside Luguo Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Luguo Sun Line = papers co-authored together Luguo Sun links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2007160
2 2017121
3 200496
4 200366
5 200363
6 201749
7 201747
8 201736
9 201631
10 201928
11 201626
12 202325
13 201224
14 202124
15 202422
16 201821
17 201221
18 202121
19 201620
20 202319

About Luguo Sun

Luguo Sun is a scholar working on Molecular Biology, Cancer Research, Immunology, Pulmonary and Respiratory Medicine and Oncology, having authored 65 papers that have together received 1.3k indexed citations. Recurring topics across this work include RNA Research and Splicing (9 papers), Histone Deacetylase Inhibitors Research (8 papers), RNA modifications and cancer (6 papers), Epigenetics and DNA Methylation (6 papers), Protein Degradation and Inhibitors (5 papers), Ferroptosis and cancer prognosis (5 papers), Natural product bioactivities and synthesis (4 papers) and MicroRNA in disease regulation (4 papers). The work is most often cited by research in Cancer Research (190 citations), Molecular Biology (745 citations), Periodontics (43 citations), Complementary and alternative medicine (69 citations) and Food Science (118 citations). Luguo Sun has collaborated with scholars based in China, Hong Kong and Russia. Frequent co-authors include Yongli Bao, Zhenguo Wu, Chunlei Yu, Yanxin Huang, Zhenbo Song, Xiang-Jiao Yang, Yin Wu, Jingwen Yi, Yuxin Li and Lihua Zheng. Their work appears in journals such as International Journal of Molecular Sciences, Scientific Reports, RSC Advances, International Journal of Biological Sciences and Biochemical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact